Cargando…
Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair
Adoptive T cell therapy using T-cell receptor (TCR)-engineered T cells allows to redirect T cell specificity and to target any antigen of interest. Here, we apply advanced genetic engineering using clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) for sim...
Autores principales: | Moosmann, Carolin, Müller, Thomas R., Busch, Dirk H., Schober, Kilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683654/ https://www.ncbi.nlm.nih.gov/pubmed/34977677 http://dx.doi.org/10.1016/j.xpro.2021.101031 |
Ejemplares similares
-
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
por: Schober, Kilian, et al.
Publicado: (2020) -
Transformation and CRISPR-Cas9-mediated homologous recombination in the fungus Rhizopus microsporus
por: Lax, Carlos, et al.
Publicado: (2022) -
T cell-specific inactivation of mouse CD2 by CRISPR/Cas9
por: Beil-Wagner, Jane, et al.
Publicado: (2016) -
Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2020) -
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
por: Schubert, Mollie S., et al.
Publicado: (2021)